News & Insights

Insights ×
Insights
17th October 2022

Pharma Licensing: the why the how and a few things to get right

Platform or asset licensing has increasingly been utilised across the bio-pharmaceutical industry to achieve Corporate objectives by sharing intellectual property (IP).  IP includes patents and know-how and third-party proprietary technologies, compounds and products, and can be used to build on existing therapeutic areas, expand into different geographies or to diversify portfolios.  A pharma licensing deal […]

Insights
8th September 2022

Global skills shortages fuel innovative HRTech solutions

The HRTech sector is more active than it has ever been before with the pandemic accelerating the adoption of technology across all HR processes. No longer seen as an administrative function, HR is now viewed as a strategic business unit focusing on the mission critical challenge of identifying and recruiting top talent but also retaining […]

Insights
27th July 2022

Transforming healthcare with real-world evidence (RWE)

The healthcare industry experienced a revolutionary shift when it switched from practising medicine as an art to evidence-based medicine, which is based on relatively simple randomised clinical trials to determine which treatment option was safe and effective. Through the years, evidence-based medicine became the gold standard for clinical development. However, this method has become less […]

Insights
5th July 2022

5 Keys to Successfully Raising Series B and Later Rounds for SaaS Companies

Much has already been written regarding raising capital that talks about the need to start a process early, getting your pitch right, and that you should talk to a wide spectrum of investors. Whilst all true, what isn’t as well covered are the specifics of what you need to do to improve your chances of […]

Insights
23rd June 2022

BIO International in San Diego: Sunny with scattered economic clouds

The biopharma universe gathered in San Diego last week for the first face to face BIO International conference in three years. Turn-out was good but below the get-together in Philadelphia in 2019. That one topped out above 17,000 attendees according to the BIO website; whisper numbers this time around were in the region of 12,000. I […]

Insights
25th May 2022

Biotech funding in a risk-off climate – does upstream trouble loom for pharma services providers?

Biotech funding is the key driver of innovation in the pharmaceutical industry and is essential in supporting the healthcare ecosystem. More than 80% of drugs marketed by large pharmaceutical companies were discovered and initially developed by biotechs1. Biotech companies also discovered more than 60% of FDA-approved “priority” drugs, which treat life-threatening conditions and offer significant […]

Insights
24th May 2022

Crossrail opens – a big day for travellers to and workers in London

At CG Results Healthcare we execute transactions around the world, with active projects in North America, Europe and Asia Pacific, so we see ourselves as a global organisation with offices and employees in London and New York, so a blog on transport in London might seem oddly parochial, but the opening of Crossrail, or the […]

Insights
6th April 2022

Partnering with Private Equity: Insights and perspectives from Tony Hill  at Sideshow and Dominic Graham at Waterland Private Equity

In February of 2021, Sideshow, an independent digital group, partnered with Waterland Private Equity to support its ambitious growth plans to continue building a group of highly connected digital brands. One year on we caught up with Sideshow’s Tony Hill, Founder and CEO, and Dominic Graham, Investment Director at Waterland to discuss the journey to […]

Insights
29th March 2022

DCAT’s Back / Back at DCAT

For the first time in forever it felt like the good old days were back in midtown Manhattan at everyone’s favourite pharma supply chain conference The hotels. The meetings. The dinners. Walking up and down Lexington Avenue and bumping into friends and colleagues. It was all happening again at DCAT last week in New York. […]

Subscribe

We add value by understanding our sectors inside-out, and we release regular industry research and reports on key trends in the technology and healthcare sectors. Fill out the form to start receiving alerts when we publish new content or to follow our latest deals, upcoming events and company updates.

  • This field is for validation purposes and should be left unchanged.